Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-19 Purchase(A) | 2023-09-22 3:44 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 5,313,100 | $1.2596 | $6,692,265 | 12,674,775 (Indirect) | View |
| 2023-02-19 Purchase | 2023-09-21 8:08 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 5,313,100 | $1.2596 | $6,692,265 | 19,209,643 (Indirect) | View |
| 2023-06-16 Purchase | 2023-06-21 4:04 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 3,350,000 | $8.12 | $27,202,000 | 13,437,473 (Indirect) | View |
| 2023-03-28 Purchase | 2023-03-30 5:47 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 200,000 | $8 | $1,600,000 | 10,087,473 (Indirect) | View |
| 2023-01-19 Purchase | 2023-01-23 6:00 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 307,500 | $9.6999 | $2,982,733 | 9,887,473 (Indirect) | View |
| 2023-01-13 Purchase | 2023-01-18 6:27 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 985,100 | $9.8442 | $9,697,527 | 9,579,973 (Indirect) | View |
| 2023-01-10 Purchase | 2023-01-12 4:47 pm | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 1,026,300 | $7.6723 | $7,874,083 | 8,594,873 (Indirect) | View |
| 2023-01-09 Sale | 2023-01-11 6:26 pm | Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner | 902,400 | $7.9148 | $7,142,343 | 3,851,507 (Indirect) | View |
| 2022-06-21 Purchase | 2022-06-23 5:21 pm | Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner | 477,400 | $5.5761 | $2,662,047 | 4,753,907 (Indirect) | View |
| 2022-05-05 Purchase | 2022-05-09 06:04 am | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG 10% Owner | 668,237 | $21.63 | $14,453,966 | 7,521,024 (Indirect) | View |
| 2022-05-05 Sale | 2022-05-09 06:04 am | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG 10% Owner | 668,237 | $21.63 | $14,453,966 | 7,521,024 (Indirect) | View |
| 2022-05-05 Purchase | 2022-05-09 06:01 am | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 1,062,736 | $29.02 | $30,840,599 | 11,584,280 (Indirect) | View |
| 2022-05-05 Sale | 2022-05-09 06:01 am | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 1,062,736 | $29.02 | $30,840,599 | 11,584,280 (Indirect) | View |
| 2022-01-12 Purchase | 2022-01-12 6:12 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 300,000 | $37.5 | $11,250,300 | 11,584,280 (Indirect) | View |
| 2021-12-01 Purchase | 2021-12-10 6:50 pm | Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner | 185,941 | $1.66 | $308,662 | 0 (Indirect) | View |
| 2021-12-01 Sale | 2021-12-10 6:50 pm | Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner | 5,887,610 | $1.6545 | $9,741,063 | 0 (Indirect) | View |
| 2021-03-31 Purchase | 2021-11-30 6:07 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 393,168 | $8.8887 | $3,494,733 | 6,534,868 (Indirect) | View |
| 2021-03-31 Sale | 2021-11-30 6:07 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP Biotech Opportunity GP LLC Director | 208,142 | $9.9578 | $2,072,642 | 6,534,868 (Indirect) | View |
| 2021-09-30 Sale | 2021-10-01 7:39 pm | Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner | 5,000,000 | $5.012 | $25,059,900 | 81,077 (Indirect) | View |
| 2021-04-30 Purchase | 2021-05-04 4:51 pm | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 221,500 | $23.24 | $5,147,444 | 7,520,424 (Indirect) | View |
| 2021-04-23 Purchase | 2021-04-27 6:23 pm | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC NODELMAN OLEG Director 10% Owner | 147,300 | $23.63 | $3,480,233 | 7,298,924 (Indirect) | View |
| 2021-04-09 Purchase | 2021-04-13 5:55 pm | Nuvation Bio Inc. | NUVB | NODELMAN OLEG EcoR1 Capital LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Panacea Holdings LLC Biotech Opportunity GP LLC Director | 464,500 | $9.8915 | $4,594,594 | 6,721,252 (Indirect) | View |
| 2021-04-09 Purchase | 2021-04-13 3:10 pm | Panacea Acquisition Corp. II | PANA | EcoR1 Panacea Holdings II LLC NODELMAN OLEG EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC Director 10% Owner | 545,000 | $10 | $5,450,000 | 545,000 (Direct) | View |
| 2021-03-24 Purchase | 2021-03-25 11:14 am | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 875,000 | $20.75 | $18,156,250 | 11,034,280 (Indirect) | View |
| 2021-03-08 Purchase | 2021-03-10 5:53 pm | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC 10% Owner | 3,308,800 | $18.93 | $62,622,736 | 7,151,624 (Indirect) | View |
| 2021-02-23 Purchase | 2021-02-25 6:00 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 55,200 | $21.24 | $1,172,385 | 10,159,280 (Indirect) | View |
| 2021-02-23 Purchase | 2021-02-25 5:58 pm | ANAPTYSBIO INC | ANAB | EcoR1 Capital LLC 10% Owner | 29,500 | $25.48 | $751,657 | 3,842,824 (Indirect) | View |
| 2021-02-18 Purchase(A) | 2021-02-23 3:57 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 44,100 | $23.65 | $1,043,075 | 10,104,080 (Indirect) | View |
| 2021-02-18 Purchase | 2021-02-22 4:24 pm | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 44,100 | $3.6758 | $162,103 | 10,104,080 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-03-26 12:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | EcoR1 Capital LLC 10% Owner | 0 | $0 | 164,424,420 (Indirect) | View |
Ownership | 2023-12-27 4:04 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | EcoR1 Capital LLC 10% Owner | 0 | $0 | 7,396,979 (Indirect) | View |
Ownership | 2023-10-16 3:42 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner | 0 | $0 | 13,330,736 (Indirect) | View |
Ownership | 2023-07-31 1:55 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | EcoR1 Capital LLC 10% Owner | 0 | $0 | 19,364,688 (Indirect) | View |
Ownership | 2023-06-05 4:09 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | EcoR1 Capital LLC 10% Owner | 0 | $0 | 5,000,000 (Indirect) | View |
| 2023-04-28 Disposition | 2023-05-02 5:15 pm | N/A N/A | Panacea Acquisition Corp. II | PANA | EcoR1 Panacea Holdings II LLC EcoR1 Capital Fund L.P. EcoR1 Capital Fund Qualified L.P. EcoR1 Venture Opportunity Fund LP EcoR1 Capital LLC Biotech Opportunity GP LLC NODELMAN OLEG Director 10% Owner | 545,000 | $0 | 0 (Direct) | View |
Ownership | 2023-01-06 9:30 pm | N/A N/A | Graphite Bio Inc. | GRPH | EcoR1 Capital LLC 10% Owner | 0 | $0 | 8,538,446 (Indirect) | View |
Ownership | 2022-11-01 3:23 pm | N/A N/A | Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner | 0 | $0 | 7,568,573 (Indirect) | View |
Ownership | 2022-04-25 9:30 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | EcoR1 Capital LLC 10% Owner | 0 | $0 | 4,276,507 (Indirect) | View |
Ownership | 2021-11-18 1:00 pm | N/A N/A | Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner | 0 | $0 | 5,701,669 (Indirect) | View |
Ownership | 2021-09-22 3:30 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner | 0 | $0 | 5,081,077 (Indirect) | View |
| 2021-06-18 Exercise | 2021-06-22 5:05 pm | 2021-02-17 2021-06-18 | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 2,500 | $0 | 11,284,280 (Indirect) | View |
| 2021-06-18 Exercise | 2021-06-22 5:05 pm | N/A N/A | PROTHENA CORP PUBLIC LTD CO | PRTA | EcoR1 Capital LLC 10% Owner | 250,000 | $30 | 11,284,280 (Indirect) | View |